Fingerprint
Dive into the research topics of 'A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically